Junior Clinical Cooperation Unit Translational Molecular Imaging in Oncologic Therapy Monitoring

Management of cancer patients can be challenging, especially when it comes to selecting the most suitable treatment that promises the best success with minimal side effects. To monitor treatment success, regular follow-up checks are conducted. Molecular imaging plays a crucial role in this process. Radioactive substances are administered to the patient to visualize biological processes non-invasively using Positron Emission Tomography (PET). The combination of PET with Computed Tomography (PET/CT) or Magnetic Resonance Imaging (PET/MRI) allows us to capture functional and morphological information simultaneously.

Our goal is to harness the capabilities of molecular imaging, especially PET, to translate research results into clinical practice. In our clinical cooperation unit, experts from various disciplines, including nuclear medicine physicians, radiologists, radiopharmacists, and medical physicists work together on the development and establishment of innovative PET tracers using cutting-edge technology such as the long-axial field of view PET/CT, PET/MRI, and photon-counting CT to advance personalized oncology. In doing so, we aim to improve the early detection of cancer and precise prediction of therapy success for our patients. Our work represents a significant step toward precision medicine for oncology patients.